(NASDAQ:IPSC), PHILADELPHIA, Aug. 22, 2025 (GLOBE NEWSWIRE) — Century Therapeutics, Inc. ('Century', NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today announced that Brent Pfeiffenberger, Pharm.D., Chief Executive Officer of Century Therapeutics, will share a company presentation at the H.C. Wainwright 27th Annual Global […]

(CNSX:AIDR),(OTC US:TREIF),(OTCQB:TREIF),(Boerse Frankfurt – Freiverkehr:939), Vancouver, British Columbia, Aug. 22, 2025 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc (formerly Treatment.com AI Inc.). (the “Company“) (CSE: AIDR; OTC: TREIF; FFA: 939) is pleased to announce that, further to its news release dated 25th July, 2025, it has closed its non-brokered private placement of 3,677,400 special warrants

SAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) — BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, today announced the first patient dosed in the expansion cohorts of the SOLARA trial (NCT06706076), the first-in-human trial of BH-30643, a first-in-class, macrocyclic,

(TSX:ABHI),(TSX:BCHI),(TSX:CCHI),(TSX:CQHI),(TSX:CRHI),(TSX:ENHI),(TSX:RYHI),(TSX:SHHI),(TSX:SUHI),(TSX:TDHI),(TSX:ECHI), TORONTO, Aug. 22, 2025 (GLOBE NEWSWIRE) — Ninepoint Partners LP, one of Canada's leading independent investment managers, is pleased to announce the launch of eleven new ETFs on the Toronto Stock Exchange (TSX) today. Canadian investors now have access to Ninepoint HighShares ETFs through the following newly listed tickers: ETFs Ticker (TSX) Risk Rating

(NASDAQ:IXHL), MELBOURNE, Australia and NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company developing innovative combination therapies for high-impact conditions, today announced that its Board of Directors has authorized a share repurchase program (the “Repurchase Program”) for up to $20 million of the

(NASDAQ:HOVR),(NASDAQ:HOVRW), TORONTO, Aug. 22, 2025 (GLOBE NEWSWIRE) — New Horizon Aircraft (NASDAQ: HOVR), doing business as Horizon Aircraft (“Horizon” or the “Company”), an advanced aerospace engineering company and developer of one of the world's first hybrid electric Vertical Take-Off and Landing (VTOL) aircraft, today provided its business update and financial results for the fourth quarter

(NASDAQ:GNTX), ZEELAND, Mich., Aug. 22, 2025 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected car, dimmable glass, fire protection technologies, medical devices, and consumer electronics, today announced that its Board of Directors recently declared a quarterly cash dividend of $0.12 (12 cents) per share that will be payable

Oak Ridge, Tennessee, Aug. 22, 2025 (GLOBE NEWSWIRE) — LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that John Olvera has been appointed as its Integrated Safety Analysis Manager. “I'm very pleased with this opportunity to work

(NASDAQ:XOS), LOS ANGELES, Aug. 22, 2025 (GLOBE NEWSWIRE) — Xos, Inc., a leading manufacturer of mediumâ€'duty electric vehicles and mobile charging solutions, today announced that John F Smith has been appointed to the Company's Board of Directors, effective August 18, 2025. With Mr. Smith's appointment, the Board has increased from eight to nine directors. Mr.

Oula, the maternity care practice offering prenatal care, hospital birth, postpartum support, and gynecology, is ranked No. 21 on the 2025 Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The annual list, compiled by Inc. magazine, provides a data-driven look at the most successful companies within the economy's most